What is ADHD Treatment?
The most common neurodevelopmental illness in children is attention deficit hyperactivity disorder (ADHD). ADHD is typically diagnosed in childhood and persists into adulthood. Children with ADHD may daydream excessively, forget or lose things, have problems resisting temptation, have trouble taking turns, have difficulty getting along with others, be extremely energetic, and have difficulty paying attention. Stimulant and non-stimulant medications are used to treat attention deficit hyperactivity disorder (ADHD).
The market study is broken down by Type (Methylphenidate, Lisdexamfetamine, Dexamfetamine, Atomoxetine, Guanfacine and Others) and major geographies with country level break-up.
Mergers and acquisitions, expansions, investments, new service launches, and collaborations are among the companies' favoured techniques for exploring the market. Players are expanding and acquiring businesses in new geographies in order to get a competitive edge through synergy. The major key players are contributing there share for increasing company growth. Manufacturers are aiming their products at both children and adults with ADHD. Certain prescriptions are flavoured to make them more appealing to children, whereas the purpose for adults is to offer a long-lasting effect so that they don't have to take as many tablets each day. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
Amneal Pharmaceuticals, Inc (United States), Eli Lilly and Company (United States), Novartis International AG (Switzerland), Janssen Pharmaceuticals, Inc (Belgium), Mayo Clinic (United States), RespireRx Pharmaceuticals Inc (United States), Otsuka Pharmaceutical Co., Ltd (Japan), Neos Therapeutics, Inc. (United States), Takeda Pharmaceutical Company Limited (Japan) and GlaxoSmithKline plc (United Kingdom) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Noven Pharmaceuticals, Inc (United States) and Purdue Pharma L.P. (United States).
Segmentation Overview
AdvanceMarketAnalytics has segmented the market of Global ADHD Treatment market by Type, Application and Region.
On the basis of geography, the market of ADHD Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Medications will boost the ADHD Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-User, the sub-segment i.e. Retail Pharmacy will boost the ADHD Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Age, the sub-segment i.e. Adult (Aged 18 and above) will boost the ADHD Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
In 2021, The US Food and Drug Administration approved two new ADHD medications in the spring. Qelbree is a nonstimulant drug, while Azstarys is a stimulant. Both are appropriate for children aged six and up.
Market Trend
- Increasing demand of Azstarys which is stimulant medication
Market Drivers
- Rising Prevalence of ADHD Treatment
- Growing Clinical Trials by Companies and Academic Institutes
- Need for Continuous Cognitive Improvement in Students
Opportunities
- Increasing the Product's Marketing and Partnership Agreements
Restraints
- Side-Effects Associated with ADHD Drugs
- High Cost of ADHD Drugs
Challenges
- New alternative treatment methods are launched
- Inappropriate Funding Procedures
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have the better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with purpose to understand companys positioning regarding market value, volume and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders etc. and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, analyst team keeps preparing set of questionnaires and after getting appointee list; the target audience are then tapped and segregated with various mediums and channels that are feasible for making connection that includes email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey etc.
Frequently Asked Questions (FAQ):
1. What all players are profiled in the study?
The standard version of the report profiles players such as Amneal Pharmaceuticals, Inc (United States), Eli Lilly and Company (United States), Novartis International AG (Switzerland), Janssen Pharmaceuticals, Inc (Belgium), Mayo Clinic (United States), RespireRx Pharmaceuticals Inc (United States), Otsuka Pharmaceutical Co., Ltd (Japan), Neos Therapeutics, Inc. (United States), Takeda Pharmaceutical Company Limited (Japan) and GlaxoSmithKline plc (United Kingdom) etc.
2. Can we have customized study for ADHD Treatment Market?
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
3. What would be the Market Size of ADHD Treatment Market by 2027?
Analysts at AMA estimates ADHD Treatment Market to reach USD Million by 2027.